EIF2A and neoplasm: Across a variety of cancers, eIF2α phosphorylation is positively correlated with calreticulin (CRT) exposure, higher tumor immune infiltration (by dendritic cells (DCs) and cytotoxic T lymphocytes (CTLs)) and better clinical outcome in patients [6,7,12,13].